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The cause of the flushing and central erythema
of the face in rosaeea is unknown. Fairhurn (1)
measured the rate of local clearance of radio-
sodium after injection into the face, and his re-
sults showed a trend towards increased local
blood flow in patients with rosacea compared with
controls. Borne (2) had been unable to demon-
strate this by skin temperature measurements.
Episodes of flushing of the face are a
characteristic feature of the carcinoid syndrome.
In some cases permanent red hypercmia of the
face and neck may develop after years of inter-
mittent flushing (Thorson, (3)) and this may be
associated with patchy cyanosis and tel-
angiectasia. The cause of this syndrome is an
excess of circulating S - hydroxytryptamine
(serotonin) and Schneckloth et at., (4) have shown
that intravenous administration of 5-hydroxy-
tryptamine produces flushing of the face and
other clinical manifestations of the carcinoid syn-
drome. Infusion of 5-hydroxytryptaminc into
the human brachial artery causes a decrease in
the forearm and hand blood flow with flushing of
the skin and later cyanosis of the fingers (Roddie
et at., (5)). They conclude that 5-hydroxytrypta-
mine causes a constriction of vessels concerned
with peripheral resistance and dilatation of
minute vessels responsible for the colour of the
skin.
5-hydroxytryptamine is derived from the
essential amino acid tryptophan and is rapidly
metabolized by monoamine oxidase to 5-by-
droxyindoleacetic acid which is excreted in the
urine.
The object of this paper is to present the results
of estimations of the urinary excretion of 5-by-
droxyindoleacetic acid in patients with rosacea.
MATERIALS AND MRTIIOD5
22 patients (8 males and 14 females) with active
rosacea were studied. Their ages ranged from 26
to 64 years and the duration of the rosacea from
one month to 25 years. A history of frequent
flushing of the face was given by 16 patients
(73%).
The S hydroxyindoleacetic acid content was
estimated by the method of Hanson and Serin
(6), on 4 ml. of a 24 hour specimen, collected with
glacial acetic acid as preservative (MacFarlane
et al., (7)). Readings were made on a Unicam
S.P. 600 and the results read from a calibration
curve prepared from the pure substance.
The 24 hr. excretion of 5-hydroxyindoleacctic
acid in 26 normal subjects, whose ages ranged
from 18 to 58, was also estimated. The mean of
these observations was 7.2 mg. with a range of
TABLE I
24 hour excretion of 5-hydroxyindoleacetic acid in
patients with rosacea compared with normal
contrals. The difference between the means is not
significant
Rosacea Controls
Number
24 hour excretion of
5 - hydroxyindole-
acetic acid
Mean
22
3.6—12.9 mg.
6.83 mg.
26
3.1—12.2 mg.
7.2 mg.
= 0.277
n = 46
p = <0.8
3.1—12.2 mg. and Standard Deviation of 2.5. We
consider the upper limit of normal to be the mean,
plus twice the Standard Deviation, that is 12.2
mg. per 24 hours.
RESULTS
The results are shown in Table I. There is no
significant difference in the 24 hour urinary ex-
cretion of 5-hydroxyindoleacetic acid in patients
with rosacea as compared with the control group
(p = <0.8). One patient had achlorhydria and 4
patients had hypochlorhydria, as indicated by the
Diagnex test, but the excretion of 5-hydroxyin-
doleacetic acid in these cases was well within the
normal range. Although gastric acidity has been
discounted as a factor in rosacea (Brown et at.,
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(5)) it was thought worth while to compare the
gastric acidity with the excretion of 5-hydroxy-
indoleacetic acid because administration of
serotonin, or its precursor 5-hydroxytryptophan,
has been shown to inhibit spontaneous gastric
secretion in animals (ilaverback ct al., (9)). These
workers also found that serotonin was a potent
stimulus to intestinal motility, and in the car-
cinoid syndrome excess of serotonin has been
associated with hypermotility of the gut.
(Sjoerdsma at al., (10)).
SUMAIARY
The 24 hour urinary excretion of the 5-hy-
droxytryptamine (serotonin) metabolite 5-hy-
droxyindoleacetic acid in 22 patients with rosacea
is normal.
It is concluded that 5-hydroxytryptamine is
not a factor in the pathogenesis of rosaeea.
We wish to thank Dr. F. F. Hellier and Dr. S. T.
Anning for permission to investigate patients
under their care, and Professor G. H. Lathe in
whose laboratory the 5 H.I.A.A. analyses were
made.
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